e.g. Tata motors, Reliance MF, 500570

Akums Drugs & Pharmaceuticals Ltd. - Research Center

544222 AKUMS Group (B) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23
Income
Operating income 1,311.78 1,444.12 1,286.83
Expenses
Material consumed 824.72 893.26 805.05
Manufacturing expenses 45.36 42.40 42.04
Personnel expenses 201.74 175.28 147.30
Selling expenses - - -
Adminstrative expenses 101.47 459.84 50.57
Expenses capitalised - - -
Cost of sales 1,173.29 1,570.78 1,044.95
Operating profit 138.50 -126.66 241.88
Other recurring income 124.19 94.12 96.15
Adjusted PBDIT 262.69 -32.54 338.03
Financial expenses 15.31 18.31 13.18
Depreciation 39.55 32.69 30.00
Other write offs - - -
Adjusted PBT 207.84 -83.54 294.85
Tax charges 46.84 62.52 24.89
Adjusted PAT 161.00 -146.06 269.96
Non recurring items -0.07 -21.56 -144.53
Other non cash adjustments - - -
Reported net profit 160.93 -167.63 125.43
Earnigs before appropriation 456.32 295.39 476.79
Equity dividend - - -
Preference dividend - - -
Dividend tax - - -
Retained earnings 456.32 295.39 476.79
Close
Add Akums Drugs & Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Akums Drugs & Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback